Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of CellSeed Inc.
No Price
Closing Price XTKS 01.05.2026:
272,00 JPY
01.05.2026 05:38
Current Prices from CellSeed Inc.
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
Tokyo
7776.T
JPY
01.05.2026 05:38
272,00 JPY
3,00 JPY
+1,12 %
Share Float & Liquidity
Free Float98,91 %
Shares Float38,06 M
Shares Outstanding38,47 M
Company Profile for CellSeed Inc. Share
CellSeed Inc. develops cell sheet regenerative medicines. It is involved in the research, development, and commercialization of cell-sheet regenerative medicine products, such as epithelial cell sheet for esophageal regeneration, regenerated cartilage sheet, and chondrocyte sheet for the treatment of knee osteoarthritis. The company also offers UpCell, a temperature-responsive cell cultureware for cell-sheet engineering; RepCell, a temperature-responsive cell cutureware for cell collection; and HydroCell, a low cell binding cultureware. In addition, it provides peripheral equipment, including ThermoPlate III, a heating element made by a transparent glass plate; and cellZscope, an automated cell monitoring system, as well as contract development and manufacturing services. The company was incorporated in 2001 and is headquartered in Tokyo, Japan.
